Under the leadership of gynecologist and gynecological surgeon Omar Zwain, MD, AdventHealth for Women opened its new, multidisciplinary Comprehensive Fibroid Program at AdventHealth Winter Park in...
Under the leadership of Medical Director of Genomics and Personalized Health Majed Dasouki, MD, AdventHealth for Children is recruiting patients for a new Phase III clinical trial to evaluate the...
Hepato-pancreato-biliary (HPB) surgeon Andrew Guzowski, MD, performed AdventHealth’s first liver histotripsy, a non-invasive treatment for certain patients with unresectable liver tumors.
Explore the healing power of music for stroke survivors and their families in this episode of the Inspiring Wholeness podcast.
Dr. Andrew Weinfeld will be responsible for executing clinical and organizational strategy, improving clinical effectiveness and patient safety, and delivering exceptional patient experiences for the...
Under the leadership of principal investigator Ki Hyeong Lee, MD, MS, medical director of AdventHealth for Children’s pediatric epilepsy center in Orlando, AdventHealth Orlando has been one of two...
In April 2024, the AdventHealth Neuroscience Institute became the first in Central Florida to treat brain patients with the Elekta Esprit Gamma Knife. This advanced stereotactic radiosurgery (SRS)...
The n-Lorem Foundation recently selected AdventHealth for Children in Orlando as one of the first institutions in Florida to collaborate with providing personalized antisense oligonucleotide (ASO)...
This spring, AdventHealth marked significant advancements in patient care with three “firsts” representing a leap forward in treatment of cardiovascular conditions.
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.